Cerutti Crispim, Boulos Marcos, Coutinho Arnídio F, Hatab Maria do Carmo L D, Falqueto Aloísio, Rezende Helder R, Duarte Ana Maria R C, Collins William, Malafronte Rosely S
Department of Social Medicine, Biomedical Center, Federal University of Espírito Santo, Maruípe, Vitória-ES, Brazil.
Malar J. 2007 Mar 19;6:33. doi: 10.1186/1475-2875-6-33.
Extra-Amazonian autochthonous Plasmodium vivax infections have been reported in mountainous regions surrounded by the Atlantic Forest in Espírito Santo state, Brazil.
Sixty-five patients and 1,777 residents were surveyed between April 2001 and March 2004. Laboratory methods included thin and thick smears, multiplex-PCR, immunofluorescent assay (IFA) against P. vivax and Plasmodium malariae crude blood-stage antigens and enzyme-linked immunosorbent assay (ELISA) for antibodies against the P. vivax-complex (P. vivax and variants) and P. malariae/Plasmodium brasilianum circumsporozoite-protein (CSP) antigens.
Average patient age was 35.1 years. Most (78.5%) were males; 64.6% lived in rural areas; 35.4% were farmers; and 12.3% students. There was no relevant history of travel. Ninety-five per cent of the patients were experiencing their first episode of malaria. Laboratory data from 51 patients were consistent with P. vivax infection, which was determined by thin smear. Of these samples, 48 were assayed by multiplex-PCR. Forty-five were positive for P. vivax, confirming the parasitological results, while P. malariae was detected in one sample and two gave negative results. Fifty percent of the 50 patients tested had IgG antibodies against the P. vivax-complex or P. malariae CSP as determined by ELISA. The percentages of residents with IgM and IgG antibodies detected by IFA for P. malariae, P. vivax and Plasmodium falciparum who did not complain of malaria symptoms at the time blood was collected were 30.1% and 56.5%, 6.2% and 37.7%, and 13.5% and 13%, respectively. The same sera that reacted to P. vivax also reacted to P. malariae. The following numbers of samples were positive in multiplex-PCR: 23 for P. vivax; 15 for P. malariae; 9 for P. falciparum and only one for P. falciparum and P. malariae. All thin and thick smears were negative. ELISA against CSP antigens was positive in 25.4%, 6.3%, 10.7% and 15.1% of the samples tested for "classical" P. vivax (VK210), VK247, P. vivax-like and P. malariae, respectively. Anopheline captures in the transmission area revealed only zoophilic and exophilic species.
The low incidence of malaria cases, the finding of asymptomatic inhabitants and the geographic separation of patients allied to serological and molecular results raise the possibility of the existence of a simian reservoir in these areas.
在巴西圣埃斯皮里图州大西洋森林环绕的山区,已报告有亚马逊地区以外的本地间日疟原虫感染情况。
2001年4月至2004年3月期间,对65名患者和1777名居民进行了调查。实验室方法包括薄血膜和厚血膜涂片、多重聚合酶链反应(multiplex-PCR)、针对间日疟原虫和三日疟原虫粗血期抗原的免疫荧光测定(IFA)以及针对间日疟原虫复合体(间日疟原虫及其变种)和三日疟原虫/巴西疟原虫环子孢子蛋白(CSP)抗原的抗体的酶联免疫吸附测定(ELISA)。
患者平均年龄为35.1岁。大多数(78.5%)为男性;64.6%生活在农村地区;35.4%是农民;12.3%是学生。无相关旅行史。95%的患者为首次疟疾发作。51名患者的实验室数据与间日疟原虫感染相符,这是通过薄血膜涂片确定的。在这些样本中,48份进行了多重聚合酶链反应检测。45份间日疟原虫检测呈阳性,证实了寄生虫学结果,而在一份样本中检测到三日疟原虫,两份结果为阴性。通过ELISA检测,50名接受检测的患者中有50%具有针对间日疟原虫复合体或三日疟原虫CSP的IgG抗体。在采血时未主诉疟疾症状的居民中,通过IFA检测到的针对三日疟原虫、间日疟原虫和恶性疟原虫的IgM和IgG抗体的百分比分别为30.1%和56.5%、6.2%和37.7%、13.5%和13%。与间日疟原虫反应的相同血清也与三日疟原虫反应。多重聚合酶链反应检测呈阳性的样本数量如下:间日疟原虫23份;三日疟原虫15份;恶性疟原虫9份;恶性疟原虫和三日疟原虫仅1份。所有薄血膜和厚血膜涂片均为阴性。针对CSP抗原的ELISA在检测“经典”间日疟原虫(VK210)、VK247、间日疟原虫样和三日疟原虫的样本中分别有25.4%、6.3%、10.7%和15.1%呈阳性。在传播区域捕获的按蚊仅发现嗜动物和嗜外栖种类。
疟疾病例的低发病率、无症状居民的发现以及患者的地理隔离,再结合血清学和分子学结果,增加了这些地区存在猴类储存宿主的可能性。